- Weather | Horoscope | Stocks
expressindia web
HomeBlogsCricketAstrologyShoppingTendersClassifieds OpinionsTravel Career
| Make this your homepage | Archive
Expressindia » Health & Pharma

Dishman to invest Rs 500 cr in two SEZs

Dishman Pharmaceuticals said it will invest Rs 500 crore in two special economic zones and has completed acquisition of land in this regard.

Marksans Pharma acquires UK-based Relonchem

Drug maker Marksans Pharma has acquired UK-based generic pharma company Relonchem.

ESI infrastructure below WHO standards: Study

Despite operating surplus of Rs 1,130 cr, ESI infrastructure did not match up to WHO standards, says a study.

Nectar Lifesciences to raise $50 mn

Pharmaceutical major Nectar Lifesciences will raise $50 million through the issue of securities.
Go to 1 2 3 4 5



Group Websites
Indian Express Financial Express Screen Loksatta Kashmir Live Biz Publications
Featured Services
© 2008 Indian Express Newspapers (Mumbai) Ltd. All rights reserved
The Indian Express Group | Advertise With Us | Privacy Policy | Feedback | Work With Us | Site Map